4.2 Gland, Contagious, Inflammatory & Pigment Disorders, Growths & Skin Cancers

Gland Disorders, Vascular Conditions & Skin Cancers

Quick Answer: Sebaceous gland disorders range from acne vulgaris—driven by retention hyperkeratosis, sebum overproduction, Cutibacterium acnes, and inflammation across Grades I to IV—to benign lesions like milia and sebaceous hyperplasia. Sudoriferous disorders include anhidrosis, hyperhidrosis, and miliaria rubra. Vascular disorders like rosacea produce chronic facial erythema and telangiectasias requiring non-thermal care. Cutaneous neoplasms range from precancerous actinic keratosis to basal cell carcinoma, squamous cell carcinoma, and aggressive malignant melanoma identified via the ABCDE criteria.

---

Pathophysiology of Sebaceous Glands & Acne Vulgaris

Sebaceous glands are holocrine exocrine structures that secrete lipid-rich sebum into hair follicles. While sebum is essential for cutaneous lubrication and barrier integrity, glandular dysfunction lies at the root of the most common dermatological disease encountered by estheticians: acne vulgaris.

Acne vulgaris is a chronic inflammatory disorder of the pilosebaceous unit (comprising the hair follicle, hair shaft, arrector pili muscle, and sebaceous gland). Rather than a simple hygiene failure, acne is an intricate biological disorder governed by four interdependent etiologic pillars:

THE FOUR ETIOLOGIC PILLARS OF ACNE VULGARIS
1. Retention Hyperkeratosis (Cellular Sticking in Follicle)
                     ↓
2. Androgen Stimulation → Sebum Overproduction (Hyperseborrhea)
                     ↓
3. Anaerobic Environment → Cutibacterium acnes Proliferation
                     ↓
4. Follicular Wall Rupture → Acute Dermal Inflammation

The Four Etiologic Factors

1. Retention Hyperkeratosis: In healthy skin, dead keratinocytes lining the follicular infundibulum shed individually and wash out to the surface with sebum flow. In acne-prone individuals, a hereditary defect causes keratinocytes to proliferate rapidly and exhibit abnormal intercellular cohesion (adhering tightly instead of desquamating). These stuck cells accumulate within the follicular lumen, forming a microscopic, cohesive plug termed a microcomedone.
2. Sebum Overproduction (Hyperseborrhea): Circulating androgens—specifically testosterone and its potent active metabolite 5-alpha-dihydrotestosterone (DHT)—bind to androgen receptors on sebaceous gland sebocytes. This stimulates cellular hypertrophy and massive sebum synthesis. The hyperactive gland pumps copious lipid material into the already obstructed follicular canal.
3. Proliferation of Cutibacterium acnes: Cutibacterium acnes (formerly designated Propionibacterium acnes) is an anaerobic, gram-positive diphtheroid bacterium that resides as a commensal organism within human sebaceous follicles. When the follicular opening becomes occluded by hyperkeratotic cells, oxygen is exhausted, creating a strictly anaerobic environment. C. acnes feeds ravenously on the abundant triglycerides in sebum, breaking them down into irritating free fatty acids via bacterial lipase enzymes and multiplying exponentially.
4. Follicular Inflammation & Rupture: Proliferating C. acnes activates Toll-like receptor 2 (TLR-2) on local immune cells and follicular keratinocytes, triggering the release of potent pro-inflammatory cytokines (Interleukin-1 alpha, IL-8, and Tumor Necrosis Factor-alpha). White blood cells (neutrophils) migrate into the follicle to attack the bacteria. As digestive enzymes accumulate, the follicular epithelium thins, weakens, and eventually ruptures, discharging sebum, keratin scales, bacteria, and fatty acids into the surrounding living dermis. This induces an intense foreign-body inflammatory reaction, transforming a closed microcomedone into an erythematous papule, pustule, or deep nodule.

---

Clinical Lesion Morphology in Sebaceous Disorders

• Open Comedones (Blackheads): Non-inflammatory comedones characterized by a widely dilated follicular ostium (pore opening) packed with compacted keratin corneocytes and oxidized lipids. The dark brown or black coloration is not dirt; rather, it is the direct biochemical oxidation of melanin pigment and sebum lipids upon prolonged exposure to atmospheric oxygen at the skin surface. Open comedones are safely extracted using appropriate desincrustation and extraction instruments.
• Closed Comedones (Whiteheads): Non-inflammatory comedones where the follicular orifice remains completely sealed by a microscopic layer of intact stratum corneum. Because the impaction is shielded from atmospheric oxygen, the trapped sebum and cellular debris remain an opaque, pale off-white or yellowish color. Closed comedones present as smooth, dome-shaped, palpable bumps measuring 1 to 3 mm. They represent the primary anatomical precursors to inflammatory papules and pustules.
• Milia (Singular: Milium): Small, firm, pearly-white, round subepidermal keratin cysts measuring 1 to 2 mm in diameter. Unlike comedones, milia possess no follicular pore opening. They develop when dead epidermal corneocytes or sebaceous secretions become trapped in tiny blind pockets beneath the epidermis—frequently following superficial skin trauma, aggressive chemical peels, burns, or the application of heavy occlusive mineral-oil-based cosmetics. They are commonly distributed around the delicate periorbital eyelid skin, temples, and malar cheeks.
  • Esthetic Extraction Note: Because milia have no natural ostium, extracting a milium requires creating a microscopic piercing in the stratum corneum covering the cyst with a sterile, disposable lancet before gentle pressure is applied. New Mexico's rules do not mention lancets. However, 16.34.7.9 NMAC treats any contact with or penetration of the dermis as invasive and requires used sharps to go into an approved sharps container. Many educators refer milia to a physician; confirm the Board's position before offering lancet extraction.
• Sebaceous Hyperplasia: A benign, non-malignant lesion characterized by the abnormal hypertrophy and enlargement of sebaceous gland lobules surrounding a central follicular duct. They present as small (2 to 4 mm), raised, yellowish, flesh-colored papules characterized by a distinctive doughnut-like appearance with a central umbilication (depression).
  • Clinical Significance: Sebaceous hyperplasia is common in mature, photoaged, oily skin. However, because its raised yellowish border and central depression closely mimic early basal cell carcinoma, estheticians must never guess its identity; any suspected lesion must be referred to a dermatologist for clinical evaluation.
• Seborrhea: An abnormal, severe hypersecretion of sebum from the sebaceous glands, resulting in a persistent, excessively oily cutaneous surface, shiny facial appearance, and enlarged pores. Seborrhea frequently predisposes individuals to seborrheic dermatitis—a chronic inflammatory condition marked by yellowish, greasy, scaling plaques across the scalp, nasolabial folds, and eyebrows.

---

Clinical Acne Grading Scale (Grades I through IV)

To standardize clinical assessment and determine whether an esthetic treatment is indicated, modified, or entirely contraindicated, professional skincare adopts the four-tier acne grading scale:

Grade I (Mild Comedonal Acne)

• Morphology: Dominated by open comedones (blackheads) and closed comedones (whiteheads), with rare, occasional small inflammatory papules. There is no active dermal swelling, no cystic involvement, and no scar formation.
• Clinical Scope: Fully within the professional scope of practice for licensed estheticians. Indicated treatments include regular superficial exfoliation (alpha and beta hydroxy acids, particularly salicylic acid due to its lipophilic, pore-clearing properties), gentle ultrasonic desincrustation, and routine aseptic manual comedone extractions.

Grade II (Moderate Comedonal & Papular Acne)

• Morphology: Characterized by extensive open and closed comedones distributed across the facial zones, accompanied by an increased number of mildly inflamed erythematous papules and occasional superficial pustules. Inflammatory activity remains localized to the superficial follicle.
• Clinical Scope: Highly responsive to professional aesthetic treatments. Protocols should emphasize salicylic acid peels, high frequency (argon gas, generating germicidal ozone), and calming LED blue-light therapy (415 nm, which excites bacterial porphyrins to destroy C. acnes via singlet oxygen release). Extractions are limited exclusively to mature, non-inflamed comedones.

Grade III (Moderately Severe Inflammatory Acne)

• Morphology: Widespread, intense inflammatory presentation characterized by numerous erythematous papules, prominent purulent pustules, and early deep inflammatory nodules. Significant localized erythema, dermal edema, and tissue tenderness are evident. Post-inflammatory hyperpigmentation and early textural scarring begin to appear.
• Clinical Scope: Requires medical co-management with a board-certified dermatologist. Mechanical scrubs, granular exfoliation, stimulating facial massage, and aggressive comedone extractions are strictly contraindicated, as friction ruptures fragile pustules and spreads bacterial contamination across the face. Esthetic treatments are restricted to ultra-calming, anti-inflammatory, non-manipulative modalities (low-level LED therapy, gentle soothing enzyme masks) supporting prescribed dermatological topicals.

Grade IV (Severe Nodulocystic Acne)

• Morphology: The most severe manifestation of acne vulgaris, characterized by widespread, deeply seated, agonizing inflammatory nodules, interconnected fluctuating cysts, suppurative sinus tracts, and extensive purulent drainage. Extensive tissue destruction leads to severe, permanent atrophic scarring ("ice-pick," "boxcar," and rolling scars) or hypertrophic scarring.
• Clinical Scope: Absolute medical contraindication to aesthetic extractions and resurfacing. Estheticians must not attempt extractions or applying aggressive chemical peels to Grade IV acne. The client must be referred immediately to a medical dermatologist. Systemic pharmaceutical therapy—most notably oral isotretinoin (Accutane)—is the gold standard medical treatment to permanently alter sebaceous gland morphology and arrest tissue destruction.

---

Sudoriferous (Sweat) Gland Pathologies

Sudoriferous glands (eccrine and apocrine) regulate thermal homeostasis and waste clearance. Disorders of sweat gland secretion produce distinct clinical symptoms:

• Anhidrosis: A deficiency or total inability to produce sweat. It may be caused by autonomic nerve dysfunction, severe thermal damage to sweat glands, genetic disorders, or adverse pharmacological reactions. Individuals with anhidrosis are at severe risk of life-threatening heatstroke because their cutaneous evaporative cooling mechanism is compromised. Services generating high thermal heat (saunas, heavy thermal facial steamers) are contraindicated.
• Bromhidrosis: Foul-smelling, offensive perspiration occurring primarily in the axillary (underarm) and plantar (feet) regions. While sweat secreted by apocrine and eccrine glands is naturally sterile and odorless, bacterial flora (Corynebacterium species) break down the apocrine proteins and fatty acids on the skin surface into volatile fatty acids and ammonia, generating intense malodor.
• Hyperhidrosis: Chronic, excessive, uncontrolled perspiration far exceeding the physiological volume required for thermoregulation. Most frequently affects the palmar surfaces of the hands, soles of the feet, and axillae. Hyperhidrosis is caused by sympathetic nervous system hyperactivity, endocrine disorders (hyperthyroidism), or emotional distress. In medical dermatology, severe hyperhidrosis is frequently treated with localized botulinum toxin (Botox) injections to block acetylcholine release at sweat glands.
• Miliaria Rubra (Prickly Heat): An acute inflammatory disorder of the eccrine sweat glands characterized by the sudden eruption of small, itchy, erythematous papules and tiny vesicles accompanied by intense burning and prickling sensations. Miliaria rubra develops when eccrine sweat ducts become physically obstructed by sweat duct keratinization during periods of prolonged exposure to high ambient heat and humidity. Trapped sweat leaks into the living epidermis, provoking localized inflammation. Warm steam and occlusive heavy creams must be avoided.

---

Cutaneous Vascular Conditions

• Rosacea: A chronic, progressive inflammatory dermatosis primarily affecting the central facial convexities (nose, cheeks, chin, and central forehead). It is characterized by persistent facial erythema, episodic flushing, visible telangiectasias, inflammatory papules and pustules, and in severe advanced stages, connective tissue hypertrophy (rhinophyma—bulbous enlargement of the nose).
  • The Four Clinical Subtypes:
    1. Erythematotelangiectatic Rosacea: Persistent central facial redness, intense flushing, and visible spider veins (telangiectasias).
    2. Papulopustular Rosacea: Persistent erythema accompanied by transient inflammatory papules and pustules mimicking acne.
    3. Phymatous Rosacea: Thickened skin with irregular surface nodularity and glandular enlargement, predominantly producing rhinophyma on the nasal lobule.
    4. Ocular Rosacea: Chronic inflammation of the eyes and eyelids; manifests as watery or bloodshot eyes, foreign-body grittiness, burning, styes, and blepharitis.
  • The Critical Diagnostic Distinction: Rosacea lacks comedones. While papulopustular rosacea displays papules and pustules resembling acne, it never presents with open or closed comedones. Identifying comedones confirms acne vulgaris, whereas their total absence points toward rosacea.
  • Rosacea Environmental and Lifestyle Triggers: Extreme heat, saunas, hot showers, intense cold winds, vigorous aerobic exertion, ultraviolet radiation, spicy foods, alcohol consumption (especially red wine), caffeine, and acute emotional stress.
  • Esthetic Protocol: Thermal steamers, aggressive mechanical microdermabrasion, stiff facial brushes, high-percentage glycolic acid peels, and vigorous stimulating petrissage massage are strictly contraindicated. Treatments must incorporate cool compressions, gentle non-thermal enzymes, low-level blue/green LED light, and soothing anti-inflammatory ingredients (azelaic acid, niacinamide, bisabolol, green tea extract).
• Telangiectasias (Couperose Skin): Permanently distended, dilated, damaged superficial capillaries and post-capillary venules in the superficial papillary dermis, visible as fine, red, thread-like lines across the cheeks, nose, and chin. Telangiectasias develop when capillary walls lose their muscular tone and elasticity from chronic sun exposure, extreme temperature swings, mechanical trauma, or chronic rosacea.

---

Cutaneous Pigmentary Disorders

Pigmentary disorders arise from abnormalities in melanocyte distribution, tyrosinase enzyme activity, or melanin synthesis:

• Melasma (Chloasma / "Pregnancy Mask"): An acquired, symmetrical, patchy facial hyperpigmentation presenting as jagged, brownish or grayish-brown macules and patches across the forehead, malar cheeks, upper lip, and jawline. Melasma is strongly driven by internal hormonal fluctuations—elevated levels of circulating estrogen and progesterone during pregnancy, oral contraceptive therapy, or hormone replacement therapy (HRT)—which hyper-sensitize melanocytes to ultraviolet radiation and heat.
  • Esthetic Caution: Melasma is heat-sensitive. Aggressive thermal lasers, hot steam, and harsh chemical trauma can cause rebound melanogenesis, dramatically worsening the hyperpigmentation.
• Solar Lentigines (Liver Spots / Age Spots): Well-demarcated, flat, brown-to-blackish macules occurring on sun-exposed anatomical regions (dorsum of the hands, face, shoulders, and chest). They result from localized proliferation of melanocytes following cumulative, long-term ultraviolet exposure.
• Post-Inflammatory Hyperpigmentation (PIH): An acquired area of darkened pigmentation that develops at the site of preceding cutaneous trauma, thermal injury, chemical burns, or inflammatory lesions (such as acne papules or excoriations). PIH occurs when inflammatory mediators (prostaglandins, leukotrienes) stimulate basal melanocytes to overproduce and abnormally deposit melanin granules into the basal epidermis or dermal macrophages. PIH is exceptionally prevalent in Fitzpatrick Skin Phototypes IV, V, and VI; practitioners must use extreme caution with chemical peel concentrations and avoid aggressive mechanical extractions on skin of color.
• Vitiligo: An acquired autoimmune disorder characterized by the progressive, selective destruction of cutaneous melanocytes by autoreactive cytotoxic T lymphocytes. It produces sharply demarcated, smooth, milk-white depigmented macules and patches surrounded by normal skin. Vitiligo patches completely lack melanin and are extremely vulnerable to sunburn and UV-induced carcinogenesis.
• Albinism: A rare congenital genetic disorder characterized by the complete or partial failure of melanocytes to synthesize melanin in the skin, hair, and irises of the eyes. Most forms result from an inherited autosomal recessive mutation in the gene encoding the copper-dependent tyrosinase enzyme. Individuals with albinism have pale white skin, white hair, pink or pale blue eyes, severe photophobia, and an extreme vulnerability to solar burns and skin cancers.

---

Cutaneous Neoplasms & Skin Cancer Screening

Cutaneous malignancies represent the most common forms of human cancer. More than 5 million cases of skin cancer are diagnosed in the United States annually. Estheticians see clients' skin up close and often, so they are well placed to notice a suspicious lesion and recommend a dermatologist visit.

1. Actinic Keratosis (AK) — The Precancerous Marker

• Pathology: An intraepidermal precancerous lesion characterized by atypical keratinocyte proliferation caused by cumulative, long-term ultraviolet radiation damage.
• Morphology: Presents as a rough, gritty, sandpaper-textured, scaly, erythematous or brownish macule or thin plaque. AKs are often palpated before they are clearly seen, feeling like tiny sandpaper patches on the scalp, forehead, nose, ears, and hands.
• Significance: Approximately 5% to 10% of untreated actinic keratoses progress directly into invasive squamous cell carcinoma. Actinic keratoses require immediate referral to a dermatologist for medical cryotherapy, topical 5-fluorouracil, or photodynamic therapy.

2. Basal Cell Carcinoma (BCC) — Most Common

• Pathology: Arises from abnormal proliferation of non-cornifying basal keratinocytes in the stratum basale of the epidermis. It accounts for approximately 80% of all diagnosed skin cancers.
• Morphology: The classic presentation of nodular BCC is a smooth, translucent, pearly or waxy raised border, with delicate surface telangiectasias (spider veins) winding across the lesion, and a central depression or crater that frequently crusts, bleeds easily, and persistently fails to heal.
• Prognosis: Basal cell carcinoma is very slow-growing and has an exceptionally low rate of distant metastasis (< 0.1%). However, if left untreated, BCC acts locally invasive, progressively eroding and destroying underlying facial cartilage, soft tissues, bone, and nerves (historically termed a "rodent ulcer").

3. Squamous Cell Carcinoma (SCC)

• Pathology: The second most common form of skin cancer (~20% of cases), arising from malignant proliferation of spinous keratinocytes in the stratum spinosum. It is directly linked to cumulative lifetime ultraviolet radiation exposure.
• Morphology: Presents as a firm, persistent, indurated, erythematous, scaly red papule or crusted hyperkeratotic nodule with sharply defined or irregular borders. The surface is often verrucous (wart-like) or ulcerated, bleeding easily when manipulated.
• Prognosis: Unlike basal cell carcinoma, squamous cell carcinoma possesses a significant propensity to metastasize to regional lymph nodes and internal organs (roughly 2% to 5% overall metastasis rate, rising higher on the ears, lips, and mucosal surfaces). Requires prompt surgical excision with clear histological margins.

4. Malignant Melanoma — Deadliest Malignancy

• Pathology: The most deadly and aggressive form of skin cancer, originating from the malignant neoplastic transformation of melanocytes. Although melanoma accounts for only about 1% of all diagnosed skin cancers, it causes the vast majority of skin cancer deaths worldwide due to its rapid propensity for early lymphatic invasion and hematogenous systemic metastasis.
• Risk Factors: History of severe blistering childhood sunburns, intermittent intense UV exposure, indoor tanning bed use, multiple dysplastic nevi, fair skin phototypes (Fitzpatrick I and II), and genetic mutations (CDKN2A, BRAF).

The Clinical ABCDE Recognition Criteria

To standardize early visual identification of malignant melanoma, the American Cancer Society and dermatological academies established the universally utilized ABCDE clinical criteria:

• A — Asymmetry: If an imaginary line is drawn through the center of the pigmented lesion, the two halves do not match in shape, size, or contour. Benign nevi are typically symmetrical, round, or oval.
• B — Border Irregularity: The perimeter or edges of the lesion are scalloped, notched, ragged, blurred, or poorly defined, fading indistinctly into surrounding skin rather than displaying a clean, smooth, continuous boundary.
• C — Color Variation: The pigmentation is heterogeneous and non-uniform. While benign moles display a single uniform shade of brown, melanomas exhibit multiple hues—varying shades of tan, dark brown, blue-black, jet black, and occasionally areas of pink, red, or depigmented white (indicating immune regression).
• D — Diameter: The lesion measures greater than 6 millimeters (mm) across—roughly the physical diameter of a standard pencil eraser. (Note: Early melanomas can present smaller than 6 mm, but any lesion exceeding this threshold demands close evaluation).
• E — Evolving / Elevation: Any noticeable change in the lesion's size, shape, surface elevation, color, or symptoms over time. If a preexisting mole begins to grow, darken, elevate, bleed, ooze, itch, or become tender, it must be evaluated immediately. An evolving lesion is considered the single most sensitive indicator of malignancy.

---

Glandular, Vascular & Neoplastic Pathologies Reference Matrix

---

Contagious Conditions: Do Not Serve, Refer

NIC lists contagious diseases separately because they change your decision from "modify the service" to "no service today." Never treat over a contagious condition. Postpone the appointment, recommend a physician, and disinfect everything the client touched.

Inflammatory Conditions

Dermatitis simply means inflammation of the skin. The exam expects you to know these forms:

• Irritant contact dermatitis: direct damage from a harsh substance or overuse, such as frequent hand washing, strong chemicals, or over-exfoliation. It is the most common occupational skin problem for salon workers. Gloves and good hand care prevent it.
• Allergic contact dermatitis: an immune reaction that appears only after you have been sensitized to a substance. Common triggers are fragrance, preservatives, nickel, and hair or lash dyes. A reaction usually appears 24 to 72 hours after exposure. This is why tint, adhesive, and depilatory services require a patch test.
• Eczema (atopic dermatitis): a chronic, itchy, dry, inflamed condition. It is not contagious. Avoid fragrance and aggressive exfoliation, and refer flare-ups to a physician.
• Psoriasis: a chronic autoimmune condition with red patches and silvery scales, often on the scalp, elbows, and knees. It is not contagious. Do not exfoliate or pick at the plaques; refer.
• Seborrheic dermatitis: red, greasy, yellowish scaling around the nose, eyebrows, and scalp.
• Perioral dermatitis: small red papules around the mouth and nose, often linked to heavy creams or topical steroids.
• Rosacea (covered above) is also an inflammatory condition. Remember that rosacea has no comedones.

Skin Growths